An experimental drug was produced clinically meaningful pain relief among surgical and non-surgical pain conditions, and the therapy could fill the gap between safe, low-efficacy medicines and opioid treatments, its manufacturer said Jan. 30.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
